On the recommendation of Dean Jane Philpott, Dr. Matthew Evans, Provost and Vice-Principal (Academic), has appointed Dr. Chandra Tayade as Vice-Dean, Basic and Public Health Sciences (VD-BPHS) effective October 1, 2023 until June 30, 2028.
Reporting to the Dean, the VD-BPHS position on the decanal team has responsibility for faculty relations in the Departments of Biomedical and Molecular Sciences, Public Health Sciences, as well as non-clinical components of the Department of Pathology and Molecular Medicine.
The VD-BPHS’s responsibilities include human resources management, strategic direction of non-clinical faculty in the School of Medicine, as well as overseeing the Associate Dean, Graduate and Post-Doctoral Research and the Associate Dean, Undergraduate Health Sciences.
A professor in the Department of Biomedical and Molecular Sciences, Dr. Tayade is an accomplished researcher and administrator. Since July 2019, Dr. Tayade has served as Associate Dean, Graduate and Post-Doctoral Research and Director of the MD-PhD Program. Since July 2018, he has also been Director of the Pharmaceutical and Healthcare Management and Innovation graduate program.
Dr. Tayade trained in India, earning his Ph.D. (Infectious Immunology) and M.V.Sc (Mucosal Immunology) at the Indian Veterinary Research Institute, as well as a Doctor of Veterinary Medicine at Nagpur Veterinary College. He completed a Postdoctoral Fellow in Reproductive Immunology at the University of Guelph.
Dr. Tayade’s career accolades include a Mihran and Mary Basmajian Award for research excellence, a Knowledge Translation Award from the American Society for Reproductive Immunology, an Early Researcher Award for promising research in endometriosis from Canada’s Ministry of Research and Innovation, and the J Christian Herr Award from the American Society for Reproductive Immunology for outstanding contribution in research.
Dr. Tayade’s research is focused on understanding the pathophyisology of endometriosis. Specifically, he is interested in how immune dysfunction in endometriosis patients contributes to the lesion initiation and survival. His laboratory is investigating specific immune mechanisms and therapeutics in pre-clinical models of endometriosis that can be safely targeted. Dr. Tayade’s research is funded by operating grants from the Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council and Aurinia Pharmaceuticals.